CHAIR
:
SPEAKER
(S):
Dr. Marco Cacciuttolo, CEO , PERCIVIA
John Cox, PhD, Senior Vice President, Global Manufacturing , Biogen Idec, Inc
Parrish Galliher, MS, President, Founder & CTO , Xcellerex, Inc
Ashley Lawton, PhD, VP of Business Development , GTC Biotherapeutics, Inc
Hubert Scoble, Wyeth
Description
"Since its inception, the biotechnology industry has depended on new technologies for the discovery and development of products. Manufacturing, although essential, has been positioned as a step in the commercialization process. With rapid growth in the number of biopharmaceutical products on the market and the advent of follow-on biologics, however, manufacturing is becoming a strategic, enabling technology that is allowing innovative companies with high-efficiency expertise to participate in product development. This panel will look at a number of companies that are leveraging unique manufacturing expertise to develop biopharmaceuticals and their product development strategies."
Objective1:Explore how biotech manufacturing has become a productenabling technology.
Objective2:Examine how manufacturing has become an integral part of product development.
Objective3:Explain how to leverage manufacturing expertise as a competitive advantage.